Methylenedioxyallylamphetamine (MDAL or 3,4-methylenedioxy-N-allylamphetamine) is a lesser-known drug. It is the N-allyl derivative of 3,4-methylenedioxyamphetamine (MDA).
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDAL's minimum dose as 180 mg orally and its duration as unknown. MDAL produces few to no effects on its own, but may enhance the effects of psychedelic drugs like LSD.
The chemical synthesis of MDAL has been described.
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.